Related Experiment Videos
Pulmonary venous velocity patterns in mitral stenosis
N Ara1, R A Nishimura, A J Tajik
1Division of Cardiovascular Diseases, Mayo Clinic and Foundation, Rochester, MN 55902, USA.
Summary
Pulmonary venous (PV) velocity ratios are used to assess heart diastolic function. This study found no characteristic PV velocity pattern in mitral stenosis patients across different severity levels.
Area of Science:
- Cardiology
- Echocardiography
- Cardiac Physiology
Background:
- Pulmonary venous (PV) velocities via transthoracic echocardiography assess diastolic function.
- The systolic/diastolic (S/D) PV velocity ratio reflects early diastolic filling and left atrial pressure (LAP).
- Mitral stenosis (MS) involves impaired filling and elevated LAP, suggesting a potential impact on PV velocities.
Purpose of the Study:
- To investigate the pulmonary venous (PV) systolic/diastolic (S/D) velocity ratio in patients with isolated mitral stenosis (MS).
- To determine if the S/D PV velocity ratio exhibits a characteristic pattern across varying degrees of MS severity.
- To test the hypothesis that the S/D ratio is increased in mild/moderate MS and decreased in severe MS due to elevated LAP.
Main Methods:
- Retrospective analysis of transthoracic echocardiography data from patients with isolated mitral stenosis.
- Categorization of patients into mild (n=18), moderate (n=16), and severe (n=7) MS groups.
- Comparison of the S/D PV velocity ratio across the different MS severity groups.
Main Results:
- No characteristic PV velocity pattern was observed in patients with mitral stenosis.
- A wide range of S/D PV velocity ratios was found within each MS severity category.
- No significant relationship was identified between the S/D PV velocity ratio and indices of MS severity.
Conclusions:
- The S/D PV velocity ratio does not appear to be a reliable indicator of mitral stenosis severity.
- There is no characteristic pulmonary venous velocity pattern associated with mitral stenosis.
- Further research may be needed to identify reliable echocardiographic markers for assessing diastolic function in MS.